Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.
medRxiv [Preprint]. 2024 Feb 11:2024.02.09.24302395. doi: 10.1101/2024.02.09.24302395.
medRxiv. 2024.
PMID: 38370835
Free PMC article.
Preprint.
Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer.
Bright JR, Lis RT, Ku AT, Terrigino NT, Whitlock NC, Trostel SY, Carrabba NV, Harmon SA, Turkbey B, Wilkinson S, Sowalsky AG.
Bright JR, et al. Among authors: terrigino nt.
J Urol. 2022 Jul;208(1):90-99. doi: 10.1097/JU.0000000000002492. Epub 2022 Mar 1.
J Urol. 2022.
PMID: 35227084
Free PMC article.
Item in Clipboard
Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer.
Hennigan ST, Trostel SY, Terrigino NT, Voznesensky OS, Schaefer RJ, Whitlock NC, Wilkinson S, Carrabba NV, Atway R, Shema S, Lake R, Sweet AR, Einstein DJ, Karzai F, Gulley JL, Chang P, Bubley GJ, Balk SP, Ye H, Sowalsky AG.
Hennigan ST, et al. Among authors: terrigino nt.
JCO Precis Oncol. 2019;3:PO.19.00176. doi: 10.1200/PO.19.00176. Epub 2019 Sep 9.
JCO Precis Oncol. 2019.
PMID: 31528835
Free PMC article.
Item in Clipboard
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Wilkinson S, Ye H, Karzai F, Harmon SA, Terrigino NT, VanderWeele DJ, Bright JR, Atway R, Trostel SY, Carrabba NV, Whitlock NC, Walker SM, Lis RT, Abdul Sater H, Capaldo BJ, Madan RA, Gulley JL, Chun G, Merino MJ, Pinto PA, Salles DC, Kaur HB, Lotan TL, Venzon DJ, Choyke PL, Turkbey B, Dahut WL, Sowalsky AG.
Wilkinson S, et al. Among authors: terrigino nt.
Eur Urol. 2021 Dec;80(6):746-757. doi: 10.1016/j.eururo.2021.03.009. Epub 2021 Mar 27.
Eur Urol. 2021.
PMID: 33785256
Free PMC article.
Item in Clipboard
A case report of multiple primary prostate tumors with differential drug sensitivity.
Wilkinson S, Harmon SA, Terrigino NT, Karzai F, Pinto PA, Madan RA, VanderWeele DJ, Lake R, Atway R, Bright JR, Carrabba NV, Trostel SY, Lis RT, Chun G, Gulley JL, Merino MJ, Choyke PL, Ye H, Dahut WL, Turkbey B, Sowalsky AG.
Wilkinson S, et al. Among authors: terrigino nt.
Nat Commun. 2020 Feb 13;11(1):837. doi: 10.1038/s41467-020-14657-7.
Nat Commun. 2020.
PMID: 32054861
Free PMC article.
Item in Clipboard
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
Whitlock NC, Trostel SY, Wilkinson S, Terrigino NT, Hennigan ST, Lake R, Carrabba NV, Atway R, Walton ED, Gryder BE, Capaldo BJ, Ye H, Sowalsky AG.
Whitlock NC, et al. Among authors: terrigino nt.
Oncogene. 2020 Aug;39(34):5663-5674. doi: 10.1038/s41388-020-01389-7. Epub 2020 Jul 17.
Oncogene. 2020.
PMID: 32681068
Free PMC article.
Item in Clipboard
Cite
Cite